65.16
-4.84
(-6.91%)
As of 8:34:50 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 9 | 17 | 18 |
| Avg. Estimate | 5.97B | 7.46B | 26.34B | 27.32B |
| Low Estimate | 5.76B | 7.27B | 26.11B | 26.21B |
| High Estimate | 6.34B | 7.93B | 26.75B | 29.31B |
| Year Ago Sales | 5.63B | 7.11B | 26.54B | 26.34B |
| Sales Growth (year/est) | 6.17% | 4.88% | -0.74% | 3.73% |
EPS Trend
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Feb 2025) | Next Qtr. (May 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XA4.F | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Reiterates | Wedbush: Outperform to Outperform | 4/1/2025 |
| Maintains | JP Morgan: Underweight to Underweight | 3/27/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 3/11/2025 |
| Maintains | Needham: Buy to Buy | 2/3/2025 |
| Maintains | JP Morgan: Underweight to Underweight | 12/20/2024 |
| Maintains | Truist Securities: Hold to Hold | 12/20/2024 |